临床试验中绝经期血管舒缩症状结局报告的差异:一项系统综述
该系统综述检索了MEDLINE、Embase和Cochrane对照试验中心注册库(从建库至2018年5月),纳入214项以绝经期血管舒缩症状为主要结局、每组至少20名女性的随机对照试验,发现共报告49种不同的主要结局并使用16种不同的测量工具,频率和严重程度/强度的定义缺乏一致性。作者认为未来研究应纳入标准化结局测量,并通过制定核心结局集(Core Outcome Set)来实现。
要点
- 共识别出49种不同的血管舒缩症状主要报告结局和16种测量工具。
- 最常报告的结局为频率(97/214)、严重程度(116/214)、强度(28/114)或其复合结局(68/214)。
- 频率和严重程度/强度的定义缺乏一致性,限制了治疗间比较和数据合成。
核心结论
- 在治疗试验中,绝经期血管舒缩症状的报告和测量存在显著差异。
- 未来研究应纳入反映患者、临床医生和研究人员优先事项的标准化结局测量,最有效的方式是制定核心结局集(Core Outcome Set)。
- 本系统综述是制定绝经期血管舒缩症状核心结局集的第一步。
研究设计与样本
- 系统综述,检索MEDLINE、Embase和Cochrane对照试验中心注册库,从建库至2018年5月。
- 纳入标准为以绝经期血管舒缩症状为主要结局、每组至少20名女性的随机对照试验。
- 共检索到5591项研究,最终纳入214项。
主要发现
- 共识别出49种不同的血管舒缩症状主要报告结局,并使用16种不同的测量工具。
- 最常报告的结局为血管舒缩症状的频率(97/214)、严重程度(116/214)、强度(28/114)或其复合结局(68/214)。
- 血管舒缩症状频率和严重程度/强度的定义缺乏一致性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is substantial variation in how menopausal vasomotor symptoms are reported and measured among intervention studies. This has prevented meaningful comparisons between treatments and limited data synthesis. OBJECTIVES: To review systematically the outcome reporting and measures used to assess menopausal vasomotor symptoms from randomised controlled trials of treatments. SEARCH STRATEGY: We searched MEDLINE, Embase, and Cochrane Central Register of Controlled Trials from inception to May 2018. SELECTION CRITERIA: Randomised controlled trials with a primary outcome of menopausal vasomotor symptoms in women and a sample size of at least 20 women per study arm. DATA COLLECTION AND ANALYSIS: Data about study characteristics, primary vasomotor-related outcomes and methods of measuring them. MAIN RESULTS: The search identified 5591 studies, 214 of which were included. Forty-nine different primary reported outcomes were identified for vasomotor symptoms and 16 different tools had been used to measure these outcomes. The most commonly reported outcomes were frequency (97/214), severity (116/214), and intensity (28/114) of vasomotor symptoms or a composite of these outcomes (68/214). There was little consistency in how the frequency and severity/intensity of vasomotor symptoms were defined. CONCLUSIONS: There is substantial variation in how menopausal vasomotor symptoms have been reported and measured in treatment trials. Future studies should include standardised outcome measures which reflect the priorities of patients, clinicians, and researchers. This is most effectively achieved through the development of a Core Outcome Set. This systematic review is the first step towards development of a Core Outcome Set for menopausal vasomotor symptoms. TWEETABLE SUMMARY: Menopausal hot flushes and night sweats have been reported in 49 different ways in clinical research. A core outcome set is urgently required.
引用
- Iliodromiti S, Wang W, Lumsden MA, et al. Variation in menopausal vasomotor symptoms outcomes in clinical trials: a systematic review. BJOG. 2019. PMID: 31621155. doi:10.1111/1471-0528.15990
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。